science glp 1 GLP-1 for Weight Loss and Diabetes GLP-1 drug popularity is outpacing
Description
Conflict of interest BG has served as a consultant for AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Merck (MSD) and Novartis as manufacturers of DPP-4 inhibitors and has received honoraria from these companies for lectures
& Wei, W
I understand why some people do, especially with stubborn blood sugar issues, but that was not my reason
doi: 10.3389/fendo.2020.573479
Boehringer reported topline results from the mid-phase study in February 2024 and will provide a closer look at the data at EASL Friday
How does the Precision Peptide Genetic Test help me choose the right GLP-1 medication
